PROKIDNEY CORP. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prokidney Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2021 to Q3 2024.
  • Prokidney Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.93M, a 46.6% decline year-over-year.
  • Prokidney Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $16.1M, a 65.2% decline year-over-year.
  • Prokidney Corp. annual Share-based Payment Arrangement, Expense for 2023 was $30.8M, a 58.6% decline from 2022.
  • Prokidney Corp. annual Share-based Payment Arrangement, Expense for 2022 was $74.5M, a 10554% increase from 2021.
  • Prokidney Corp. annual Share-based Payment Arrangement, Expense for 2021 was $699K, a 4.25% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $16.1M $6.93M -$6.06M -46.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $22.1M $7.81M -$3.39M -30.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $25.5M $7.68M -$5.34M -41% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $30.8M -$6.37M -$15.3M -171% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $46.2M $13M +$8.15M +168% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $38M $11.2M +$3.2M +40% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $34.8M $13M -$39.7M -75.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $74.5M $8.94M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $4.84M +$4.84M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $52.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0 Sep 30, 2021 10-Q 2021-11-15
Q3 2021 $175K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.